Search Results for: US Stem Cell

Small positive step for BlueRock Therapeutics Stem Cell Therapy for Parkinson’s

/ / 4 Comments
BlueRock Therapeutics, Parkinson's disease, brain imaging

Several groups including Viviane Tabar who is a founding scientist at BlueRock Therapeutics are moving forward on potential cell therapies for Parkinson’s Disease. BlueRock just released some new data that’s worth a look. Check out the new BlueRock poster. In today’s post, I briefly discuss the new data. I also go into the larger context […]

Small positive step for BlueRock Therapeutics Stem Cell Therapy for Parkinson’s Read More »

Weekly reads: stem cell therapy for eyes research, DMD, cheating death, cancer sensors

/ / 1 Comment
stem cell therapy

Many avenues are being pursued to get stem cell therapy to the clinic for eye conditions. These different approaches employ a variety of stem cell types. In some cases, such as with iPS cells, the stem cells themselves are not transplanted. Instead, the iPS cells are used to make differentiated eye cells, such as RPE

Weekly reads: stem cell therapy for eyes research, DMD, cheating death, cancer sensors Read More »

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s

/ / 6 Comments
Knoepfler lab stem cells

Early during my postdoc I was primarily interested in the role of Myc genes both in cancer and in stem cells, work that later included embryonic stem cells. These cells are often called ES cells. At first I first started studying N-Myc in neural stem cells using a conditional knockout approach. However, soon after I was

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s Read More »

Hoping for approval, Mesoblast says FDA wants new remestemcel-L trial

/ / 1 Comment
mesoblast ceo dr silvio itescu

Australian biotech Mesoblast has had a rollercoaster ride working toward FDA approval of its mesenchymal cell therapy product remestemcel-L. They are seeking approval for use in patients with graft-versus-host disease (GvHD). More specifically, it is intended for pediatric patients with steroid-refractory acute graft versus host disease, or SR-aGVHD. This is a serious condition and new treatment

Hoping for approval, Mesoblast says FDA wants new remestemcel-L trial Read More »

Weekly stem cell reads: Google Bard AI issues, fat ball reprogramming, BrainStorm on ALS

/ / Leave a Comment
stem cell research

It’s great finding stem cell videos on YouTube that are either excellent research talks or provide important information. I recently found one such video by Shiri Gur-Cohen, which I included below. Interesting data there and Shiri is such a compelling speaker. She also won The Niche image contest one year with a cool microscopy pic

Weekly stem cell reads: Google Bard AI issues, fat ball reprogramming, BrainStorm on ALS Read More »

Update on stem cells & cell therapy for COVID trials

/ / Leave a Comment
cell therapy for COVID

From the beginning of the pandemic, I have been mostly skeptical about the idea of cell therapy for COVID including stem cell therapies. However, at the same time, I’ve closely followed the data, especially up until 2022. Now having just had a nasty bout with COVID myself for the first time this summer, I recently

Update on stem cells & cell therapy for COVID trials Read More »

Weekly reads: Vertex stem cells for diabetes update, new CRISPR , immortality

/ / 1 Comment
stem cell therapy for diabetes

Where do things stand with the investigative approach of stem cells for diabetes? 33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells, Medscape. Not the best headline given the few number of participants here. If your study has only two subjects and one responds, someone is going to say, “50% of people had a

Weekly reads: Vertex stem cells for diabetes update, new CRISPR , immortality Read More »

Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates

/ / Leave a Comment
dr. jeffrey weiss, MD Stem Cells

There is still plenty of reason to worry about unproven stem cells being marketed in the U.S. and elsewhere around the world. I’ll start with a new item here in the U.S. on a firm called MD Stem Cells and end with a newly published paper about how things are going in Poland on this

Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates Read More »

Weekly reads: stembryos or human embryo models, new Macchiarini sentence

/ / Leave a Comment
stembryos, embryo models Monash

Researchers have been making stem cell-based embryo models for years now and a few folks have taken to calling these “stembryos.” Other names like gastruloids and blastoids are sometimes used too. “Embryo models” might be the simplest and best name. The embryo model research has advanced relatively quickly from very basic, not very organized structures

Weekly reads: stembryos or human embryo models, new Macchiarini sentence Read More »

Stem cell therapy cost in 2024: data & analysis

/ / 4 Comments
stem cell therapy cost

How much does stem cell therapy cost in 2024? How have prices changed? To authoritatively answer these questions now we need data from the present and past along with expert perspectives. Some surprises come up in this new analysis. In this article Intro  | Stem Cell Therapy Cost: $10,000-$20,000 | Why do stem cells cost so much?

Stem cell therapy cost in 2024: data & analysis Read More »